Division of Epidemiology, Indian Council of Medical Research-National Institute for Cholera and Enteric Disease, Kolkata, India.
Division of Bacteriology, Indian Council of Medical Research-National Institute for Cholera and Enteric Disease, Kolkata, India.
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S754-S758. doi: 10.1093/infdis/jiab465.
Cholera remains a major contributor of diarrheal diseases and leads to substantial morbidity and mortality, particularly in low socioeconomic settings. Nonavailability of a national cholera control plan in India, compounded by underreporting of cholera cases and deficient accurate cholera hotspot estimates, has made cholera control a challenge. Obstacles in the programmatic introduction of oral cholera vaccine (OCV) lie within the infrastructure-stockpile, costing, distribution system, cold-chain mechanism, vaccine logistics, and lack of strengthened surveillance systems for adverse events following immunization. Sustained political commitment along with collaboration of people working in the media will also determine the policy outcome of OCV introduction in India.
霍乱仍然是导致腹泻病的主要原因之一,特别是在中低收入国家,会导致大量的发病率和死亡率。印度缺乏国家霍乱控制计划,加上霍乱病例报告不足和准确的霍乱热点估计不足,使得霍乱控制成为一个挑战。口服霍乱疫苗(OCV)在方案实施中存在基础设施、库存、成本、分配系统、冷链机制、疫苗物流以及强化免疫后不良事件监测系统方面的障碍。持续的政治承诺以及媒体工作者的合作也将决定印度引入 OCV 的政策结果。